# EDGAR Filing Document

**Accession Number:** 0001121404
**File Stem:** 0001193125-23-068710
**Filing Date:** 2023-3
**Character Count:** 4722
**Document Hash:** ba750c6bfc07bbe172b782cf470b6b70
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-068710.hdr.sgml**: 20230313

**ACCESSION NUMBER**: 0001193125-23-068710

**CONFORMED SUBMISSION TYPE**: S-8 POS

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230313

**DATE AS OF CHANGE**: 20230313

**EFFECTIVENESS DATE**: 20230313

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sanofi
- **CENTRAL INDEX KEY:** 0001121404
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 133529324
- **STATE OF INCORPORATION:** I0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8 POS
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-265050
- **FILM NUMBER:** 23726406

**BUSINESS ADDRESS:**
- **STREET 1:** 46 AVENUE DE LA GRANDE ARMEE
- **CITY:** PARIS
- **STATE:** I0
- **ZIP:** 75017
- **BUSINESS PHONE:** 33153774400

**MAIL ADDRESS:**
- **STREET 1:** 46 AVENUE DE LA GRANDE ARMEE
- **CITY:** PARIS
- **STATE:** I0
- **ZIP:** 75017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SANOFI-AVENTIS
- **DATE OF NAME CHANGE:** 20040826

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SANOFI SYNTHELABO SA
- **DATE OF NAME CHANGE:** 20010104

**As filed with the Securities and Exchange Commission on March 13, 2023** 

**Registration No. 333-265050** 

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**POST-EFFECTIVE AMENDMENT NO. 1** 

**TO FORM S-8** 

**REGISTRATION STATEMENT** 

***UNDER***

***THE SECURITIES ACT OF 1933***

------

## SANOFI
**(Exact name of Registrant as specified in its charter)** 

------

---

| | |
|:---|:---|
| **Republic of France** | **Not Applicable** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. Employer**<br> **Identification Number)** |

---

**46, avenue de la Grande Armée, 75017 Paris, France** 

**(Address of Registrant's principal executive offices)** 

**ACTION 2022 SHAREHOLDING PLAN** 

**(Full title of the plan)** 

**Debora C. Pellicano** 

**Vice President and Chief Financial Officer** 

**Sanofi U.S. Services Inc.** 

**55 Corporate Drive** 

**Bridgewater, New Jersey 08807** 

**Tel. No. +1 (908) 981-5000** 

**(Name, address and telephone number of agent for service)** 

***Copies to:***

**Sami Toutounji** 

**Gide Loyrette Nouel A.A.R.P.I.** 

**15 rue de Laborde** 

**75008 Paris, France** 

------

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "small reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**EXPLANATORY NOTE: DEREGISTRATION OF SECURITIES** 

This Post-Effective Amendment No. 1 to the Registration Statement on Form S-8, Registration No. 333-265050 (the "Registration Statement"), is being filed to deregister certain shares of Sanofi (the "Registrant") Ordinary Shares (the "Shares") that were registered for issuance pursuant to the Action 2022 Shareholding Plan (the "2022 Plan"). The Registration Statement, which was filed with the Securities and Exchange Commission on May 18, 2022, registered 500,000 Shares issuable pursuant to the 2022 Plan. The Registration Statement is hereby amended to deregister the 299,321 Shares that were previously registered and that remain unissued under the 2022 Plan.

------

**SIGNATURES** 

**THE REGISTRANT.** Pursuant to the requirements of the U.S. Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused Post-Effective Amendment No. 1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Paris, France on March 13, 2023.

---

| | |
|:---|:---|
| **SANOFI** | **SANOFI** |
| By: | /s/ Roy Papatheodorou |
| Name: | Roy Papatheodorou |
| Title: | Executive Vice President, General Counsel & Head of Legal, Ethics & Business Integrity |

---

Note: In reliance upon Rule 478 under the U.S. Securities Act of 1933, as amended, no other person is required to sign this Post-Effective Amendment No. 1.